tanshinone has been researched along with Liver Cirrhosis in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelmonsif, DA; Ashour, AA; El-Kamel, AH; Khalifa, HM; Ramadan, AA | 1 |
| Dong, BS; Shi, MJ; Su, SB; Yan, XL; Yang, WN; Zhang, H | 1 |
| Chen, H; Gao, Y; Ji, X; Jin, S; Li, N; Lin, Q; Liu, Y; Xu, W; Yang, N; Zhang, S | 1 |
| Cao, X; Hu, Y; Li, J; Meng, L; Meng, Z; Wang, K; Wu, J | 1 |
4 other study(ies) available for tanshinone and Liver Cirrhosis
| Article | Year |
|---|---|
Modified Lipid Nanocapsules for Targeted Tanshinone IIA Delivery in Liver Fibrosis.
Topics: Abietanes; Humans; Lipids; Liver Cirrhosis; Nanocapsules; Tissue Distribution | 2021 |
A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis.
Topics: Abietanes; Animals; Carbon Tetrachloride; Cell Line; Cell Proliferation; Hepatic Stellate Cells; Humans; Liver; Liver Cirrhosis; Male; Protein Interaction Maps; Rats, Wistar | 2020 |
Tanshinone IIA exerts therapeutic effects by acting on endogenous stem cells in rats with liver cirrhosis.
Topics: Abietanes; Animals; Carbon Tetrachloride; Cell Differentiation; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Liver Cirrhosis; Male; Rats; Rats, Sprague-Dawley; Salvia miltiorrhiza; Stem Cells | 2020 |
Enhanced hepatic targeting, biodistribution and antifibrotic efficacy of tanshinone IIA loaded globin nanoparticles.
Topics: Abietanes; Animals; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Stability; Fibrinolytic Agents; Globins; In Vitro Techniques; Liver; Liver Cirrhosis; Male; Mice; Mice, Inbred ICR; Nanoparticles; Thioacetamide; Tissue Distribution; X-Ray Diffraction | 2015 |